Back

Selecting patients for targeted therapy with early rhythm control using BMP10 blood biomarker levels

30 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Role of biomarkers in atrial fibrillation Rhythm Control, Antiarrhythmic Drugs ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Christoph Al-Taie

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

7 More presentations in this session

Presentation thumbnail
Blood biomarkers and development of Atrial Fibrillation within 1 year, in frail older patients. Outcomes of the Dutch-GERAF study.
Mrs J. Spruit (Alkmaar, NL)
Abstract Slides Video
Presentation thumbnail
Assessment of 352 plasma biomarkers for predicting ischaemic stroke risk in atrial fibrillation patients without anticoagulation - A proteomic profiling study
Associate Professor Z. Hijazi (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Identification of a lactylation-related gene signature as the novel biomarkers for early diagnosis of atrial fibrillation
Doctor X. Long (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
NT-proBNP may be used as a risk factor of stroke after the elimination of atrial fibrillation by catheter ablation
Doctor S. Kudo (Amagasaki, JP)
Abstract Slides Video
Presentation thumbnail
Inflammatory biomarkers in symptomatic atrial fibrillation: a case-control study
Doctor A. Jackson (Orebro, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Role of biomarkers in atrial fibrillation

The Event

Event poster

ESC Congress 2025

30 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Biomolecule-based prediction of sinus rhythm and interaction with early rhythm control: EAST-AFNET 4 biomolecule study
thumbnail
Congress Presentation
Cluster-specific predictors of early rhythm control in contemporary European cohort of patients with atrial fibrillation: The EHRA-PATHS Project
thumbnail
Congress Presentation
Comprehensive assessment of novel biomarkers in atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources